Al-Naamani Khalid, Al-Maqbali Ali, Al-Sinani Siham
Department of Medicine, Armed Forces Hospital, Muscat, Oman;
Sultan Qaboos Univ Med J. 2013 Aug;13(3):380-5. doi: 10.12816/0003259. Epub 2013 Jun 25.
This study aimed to describe the demographic and virological characteristics of chronic hepatitis B virus (HBV) infection in a sample of Omani patients, and indirectly assess the efficacy of hepatitis B vaccination programmes and catch-up strategies.
A retrospective study was undertaken of all patients with chronic HBV infections evaluated and followed-up at the Hepatology Clinic of the Armed Forces Hospital (AFH), Muscat, Oman, between January 2009 and April 2011.
A total of 154 patients met the inclusion criteria. The mean age of infected patients was 33 years with 72.7% being over 27 years. Females constituted 47.7% of the patients. Half of the cohort was referred either from the AFH's Obstetric Clinic (29.2%) or its Blood Bank (22.1%). A family history of chronic HBV infection was present in 70% of patients. A total of 95% had positive hepatitis B surface antigens, while only 5% had isolated total hepatitis B core antibodies. Most patients (96%) were hepatitis B e-antigen-negative. The majority (77.9%) had low HBV dioribonucleic acid levels of <2,000 IU/ml. Radiological features of liver cirrhosis were observed in 5%. Patients requiring treatment were in the minority (9%).
Almost 50% of the infected patients were female, the majority being of childbearing age. Medical authorities in Oman should consider enforcing a screening policy for all pregnant women using complete hepatitis B serological testing.
本研究旨在描述阿曼患者样本中慢性乙型肝炎病毒(HBV)感染的人口统计学和病毒学特征,并间接评估乙肝疫苗接种计划和补种策略的效果。
对2009年1月至2011年4月期间在阿曼马斯喀特武装部队医院(AFH)肝病诊所接受评估和随访的所有慢性HBV感染患者进行回顾性研究。
共有154名患者符合纳入标准。感染患者的平均年龄为33岁,其中72.7%超过27岁。女性占患者总数的47.7%。队列中的一半患者是从AFH的产科诊所(29.2%)或血库(22.1%)转诊而来。70%的患者有慢性HBV感染家族史。共有95%的患者乙肝表面抗原呈阳性,而仅有5%的患者仅有乙肝核心抗体。大多数患者(96%)乙肝e抗原阴性。大多数(77.9%)患者的HBV双核糖核酸水平较低,<2000 IU/ml。5%的患者观察到肝硬化的影像学特征。需要治疗的患者占少数(9%)。
近50%的感染患者为女性,大多数处于育龄期。阿曼的医疗当局应考虑对所有孕妇实施全面乙肝血清学检测的筛查政策。